SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum
GLD 399.29+0.9%Dec 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: flashforward2009 who wrote (177147)8/24/2021 4:26:14 PM
From: marcher1 Recommendation

Recommended By
flashforward2009

  Read Replies (2) of 218546
 
it is horrible that some u.s. residents have turned to the medication developed for farm animals,
when they really would prefer to take the medication developed for humans and used in africa to
treat "various parasitic and viral diseases."

Dec 2020:

"... ivermectin is considered a drug of choice for various parasitic and viral diseases and shown to have
in vitro effects against SARS-CoV-2.

...Data from 19 countries that participated in the World Health Organization (WHO) sponsored African
Programme for Onchocerciasis Control (APOC), from 1995 until 2015, were compared with thirty-five
(Non-APOC), countries that were not included. Information was obtained from worldometers.info database.

... APOC [ivermectin treatment] countries (vs. non-APOC), show 28% lower mortality
(0.72; 95% CI: 0.67-0.78) and 8% lower rate of infection (0.92; 95% CI: 0.91-0.93) due to COVID-19.
Conclusions: ... That a mass public health preventive campaign against COVID-19 may have taken
place, inadvertently, in some African countries with massive community ivermectin use is an attractive
hypothesis. Additional studies are needed to confirm it..."
pubmed.ncbi.nlm.nih.gov

animal meds are not the best option.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News